Menu
Recruiting NCT07007156

Is a Positive NECPAL in ICU Patients Associated With Higher Mortality

Observational Acute Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: NECPAL positive.
Who it may be relevant to
Registry conditions: Acute Disease. Basic parameters: from 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Spain
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The aim of the present study is to evaluate the usefulness of the NECPAL scale in identifying Intensive Care Unit (ICU)-admitted patients at higher risk of dying within 90 days of ICU admission

Interventions

  • Other NECPAL positive
    This group has a positive result for NECPAL scale

Primary outcome measures

  • Mortality [Time frame: From baseline to 90-day]

Eligibility criteria

Inclusion criteria

  • Patients who meet all of the following inclusion criteria may be included in the study:
  • Men and women aged 75 years or older.
  • Admission to the ICU of the study center.
  • Legal capacity to provide informed consent.
  • Signed informed consent for study inclusion, either by the participant or their legal representative.

Exclusion criteria

Participants who meet any of the following exclusion criteria may not be included in the study:

-Death within the first 24 hours of ICU admission.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Spain · 1 center
  • CSAPG — Sant Pere de Ribes

Identifiers

NCT: NCT07007156 · CSAPG-74

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗